Ann: New Independent Trial Data Supports Potential of Veyonda, page-6

  1. 697 Posts.
    lightbulb Created with Sketch. 262
    This sort of announcement does nothing for the company’s credibility imo.
    ’warmth’ isn’t even their study - and they’ve put it in a price sensitive document, and headline claim it supports Veyonda; unbelievable!!
    this sort of comparison of survivals between totally different studies is completely invalid. 71% increased survival ? Seriously?
    really poor stuff imo


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.8¢
Change
0.005(7.94%)
Mkt cap ! $19.87M
Open High Low Value Volume
6.5¢ 6.9¢ 6.5¢ $48.42K 724.1K

Buyers (Bids)

No. Vol. Price($)
1 30000 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 2284 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.